Together we will beat cancer

Donate

New link between high testosterone in men and increased risk of melanoma

Researchers have uncovered a new link between higher levels of testosterone in the blood and increased risk of melanoma skin cancer in men.

Read More

Low testosterone levels linked to reduced risk of prostate cancer

Men with unusually low amounts of testosterone in their blood are around 20% less likely to develop prostate cancer.

Read More

5 persistent myths about the causes of breast cancer

The good news is there’s no reason to be concerned about deodorants, bras, plastics and milk when it comes to breast cancer risk.

Read More

Reports that cancer is ‘mainly bad luck’ make a complicated story a bit too simple

New research predicts that 2 in 3 cancers are ‘due to bad luck’, we look at why the story is a bit more complicated than that.

Read More

How exactly does obesity cause cancer? Three leading theories

We explore the science behind how fat causes cancer.

Read More

Naturally high oestrogen levels may lower women’s bowel cancer risk

Women with naturally higher levels of the sex hormone oestrogen are more than 50 per cent less likely to develop bowel cancer after their menopause.

Read More

No, HRT isn’t ‘harmless’ – there are risks as well as benefits

Yesterday saw some bold, but extremely misleading headlines about hormone replacement therapy (HRT) being “harmless”. This unfortunate statement flies in…

Read More

Hormone replacement therapy does increase cancer risk

Cancer Research UK is deeply concerned for women’s health amid headlines that taking Hormone Replacement Therapy (HRT) is safe.

Read More

Our milestones: the birth of abiraterone for prostate cancer

This entry is part 24 of 30 in the series Our milestones

We look back to the 1990s, and to our ‘first-in-man’ trial of prostate cancer drug abiraterone – a vital step in the drug’s development

Read More

Solving a breast cancer mystery – why do ‘double-positive’ women do better?

Our researchers in Cambridge have solved a long-standing mystery in breast cancer that could lead to new trials to improve treatment for the disease.

Read More